Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis.

J E Hay1

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Clinics in Liver Disease
|November 25, 2004
PubMed
Summary
This summary is machine-generated.

Osteopenia, including osteoporosis, frequently complicates chronic cholestatic liver diseases. While its cause is unclear, it

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Natural History of Severe Acute Liver Injury.

The American journal of gastroenterology·2017
Same author

Review article: the management of cirrhosis in women.

Alimentary pharmacology & therapeutics·2014
Same author

Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis.

Journal of hepatology·2001
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Area of Science:

  • Hepatology and Bone Metabolism
  • Clinical Endocrinology
  • Transplantation Medicine

Background:

  • Osteopenia, particularly osteoporosis, is a frequent complication in patients with chronic cholestatic liver diseases.
  • The exact etiology of bone loss in these conditions remains poorly understood but is strongly linked to the cholestatic process.
  • Increased patient survival due to liver transplantation has heightened the clinical relevance of osteopenia, with fractures becoming a significant source of morbidity.

Purpose of the Study:

  • To review the clinical significance and management of osteopenia in chronic cholestatic liver diseases.
  • To highlight the diagnostic ease and prognostic value of serial measurements for osteopenia.
  • To discuss current limitations in therapeutic interventions and emphasize supportive care strategies.

Related Experiment Videos

Main Methods:

  • Review of existing literature on osteopenia in chronic cholestatic liver diseases.
  • Discussion of noninvasive diagnostic techniques for assessing bone density.
  • Analysis of the impact of liver transplantation on bone health outcomes.

Main Results:

  • Osteopenia is a common and increasingly significant complication in patients with chronic cholestatic liver diseases.
  • Noninvasive diagnostic methods are readily available for early detection and monitoring of disease progression.
  • Fracturing represents a major cause of morbidity in this patient population, especially post-liver transplantation.

Conclusions:

  • Effective therapies to treat or prevent osteopenia in chronic cholestatic liver diseases are currently lacking.
  • Supportive measures are crucial for improving skeletal health, particularly in high-risk patients awaiting or undergoing liver transplantation.
  • Further research into the pathogenesis and treatment of cholestasis-associated osteopenia is warranted.